2012 Results - Essilor

More documents

Recommendations

Info

After 2 Years of Photobiology Cell Tests, Essilor & IdV Have Released Their SCIENTIFIC DISCOVERY Phototoxicity screening and elucidation of a very specific band, 435nm +/- 20nm, that is the most noxious for target retinal cells, corresponding to the Blue-Violet light Healthy RPE* cells Degenerated RPE cells *RPE – Retinal Pigment Epithelium 2012 Results 46
Selective Light Filter to Improve Eye Protection NON-VISIBLE UV 280nm 380nm BLUE 500nm VISIBLE 780nm UV light 435nm BLUE-VIOLET light Risks even in cloudy weather (40%) Skin damage, corneal damage Crystalline-lens opacity Risks outdoor and more & more indoor (LED) CATARACT Retinal cell degeneration AMD 2012 Results 47
Page 1 and 2: 2012 Results February 28, 2013
Page 4 and 5: 2012: A Year of Acceleration 2012 R
Page 6 and 7: 2012: Step-up in Revenues from Fast
Page 8 and 9: Leveraging the Power of Partnership
Page 10 and 11: Strategy Delivering Consistent and
Page 12 and 13: Revenue Up 19.1% to €4,989m In
Page 14 and 15: Q4 Revenue Up 10.5% at Constant Exc
Page 16 and 17: Positive Contribution from All Regi
Page 18 and 19: 24 Bolt-on Acquisitions (1) Represe
Page 20 and 21: Fast-Growing Markets (1) : On Track
Page 22 and 23: Impact of PPA and Acquisition Costs
Page 24 and 25: Profit Attributable to Equity Holde
Page 26 and 27: Investing in New Capacity to Suppor
Page 28 and 29: Strong Financial Position In € mi
Page 30 and 31: Transitions: Background to discussi
Page 32 and 33: Agenda Introduction Operational and
Page 34 and 35: Many New Fields of Research… Pers
Page 36 and 37: … And Highly Promising Innovation
Page 38 and 39: … And Still Many Challenges to Me
Page 40 and 41: 40 TM
Page 42 and 43: People Can Now Live 100 Years, BUT
Page 44 and 45: Understanding Light’s Crucial Rol
Page 48 and 49: A New Technology Allowing SELECTIVE
Page 50 and 51: 2 Strategic Targets for Blue-Violet
Page 52 and 53: Launch Strategy of April 2013: Cou
Page 54 and 55: Crizal ® Prevencia: A New Step For
Page 56 and 57: Agenda Introduction Operational and
Page 58 and 59: Optical Market: An Accelerating Gro
Page 60 and 61: Need for Vision Correction is Incre
Page 62 and 63: Product Mix is Changing Rapidly Pro
Page 64 and 65: A Further 1.4 Billion People Will C
Page 66 and 67: A Fragmented Industry where Consoli
Page 68 and 69: Catch-Up Supporting Growth of the U
Page 70 and 71: Improving Distribution Networks & A
Page 72 and 73: Key Areas of Focus for 2013 Talent
Page 77 and 78: Gaining Share through Market Consol
Page 83: Leveraging our Strengths in Develop
Page 89 and 90: 2000 2001 2002 2003 2004 2005 2006
Page 91: 53,000 People and a Unique Entrepre

2012 Results - Essilor

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?